Agenus is redirecting its Phase 3 colon-cancer strategy. The biotech company said on July 13 that it will stop providing financial support for its BATTMAN study and make ROBBIN, a planned Phase 3 ...
Meta and Palantir both crushed Q1 expectations, but their valuations now live in completely different universes. The case for ...
Shares of CrowdStrike Holdings (NASDAQ:CRWD) are up 11% to $207.71 in Tuesday midday trading, leading a broad cybersecurity ...
On Tuesday, July 14, Bank of America (NYSE:BAC) blew past Wall Street's expectations and delivered results for one of its strongest quarters in years. Second-quarter revenue grew about $4.2 billion ...
Major stock indexes were mostly higher on a busy Tuesday after the June Consumer Price Index data came in softer than ...
Warren Buffett excluded the Gates Foundation from his annual Berkshire stock donations, directing billions to four ...
HSBC downgrades IBM shares to the equivalent of Sell, pointing to better investment opportunities in a basket of stocks ...
PJT Partners is a BUY: undervalued at 11.5x EV/EBITDA with a strong M&A pipeline, buybacks & dividends. Click here to read my ...
The stocks on this list have been popular with artificial investors, but they trade at excessively high premiums, especially when compared to Nvidia.
Waters Corporation stays a Hold as BD acquisition synergies offset valuation concerns. Click for this updated look at at WAT ...
Billionaire Warren Buffett omitted Bill Gates′ foundation from his annual donations this year after disclosures of the ...
Check out some of the companies making the biggest moves midday: CleanSpark — The digital infrastructure company surged 11% after securing a 20-year data center lease in Georgia, totaling $6.6 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results